Search PubMed⌕ Search

Biomedical subjects

M A Reilly

Publications and source records attributed to M A Reilly.

36 records · Page 2Linked to original sources

Comparison of in vitro and in vivo histamine methylation by tissues.

A method for determining the histamine-methylating enzyme (HME) using crude enzyme, and minute quantities of the substrate, was applied to tissues of mice, guinea-pigs and rats. Since high levels of endogenous histamine can affect the results, tissue homogenates were dialyzed prior to incubation. Findings were compared with in vivo data on methylating ability of individual tissues; most of this in vivo data is published but a new test of guinea-pig tissues was made using amodiaquine as an inhibitor. The correlation was good, better than that obtained by other procedures. It was observed that dialysis caused an increase in HME for some guinea-pig tissues, but a loss for some mouse tissues. Possible explanations are considered. Quinacrine N-mustard, a derivative of a known HME inhibitor, was tested in mice; it altered the distribution of injected 14C-histamine but showed no evidence of HME inhibition.

Amodiaquine↗

Effect of glucocorticoids on histamine metabolism in mice.

1. Histamine formation and catabolism were studied in vivo in standardized experiments; for the former, animals pretreated with inhibitors of histamine catabolism were killed 10 min after intravenous injection of (14)C-L-histidine; for the latter, no inhibitors were used and animals were killed 2.5 min after intravenous injection of (14)C-histamine. In vitro assays of histidine decarboxylase activity were also made.2. Pretreatment of adrenalectomized mice with cortisol for one day caused a major alteration in histamine formation; stomach and intestine were abnormally high in the (14)C-histamine:total (14)C ratio, while most other tested tissues were lower. Brain and thymus were unaffected. Cortisol treatment caused a marked increase in urinary excretion of both (14)C-histamine and total (14)C.3. Following injection of a rapidly absorbed corticoid, significant effects on urine and stomach were demonstrable at 30 min and 4 h, respectively.4. In cortisol-treated adrenalectomized mice histidine decarboxylase activity, relative to controls, was decreased in lung but virtually unaffected in kidney, heart, muscle and liver. In stomach, activity was increased but the statistical significance was low.5. In mice injected with (14)C-histamine, cortisol pretreatment caused a small drop in tissue levels of (14)C-histamine, (14)-methylhistamine and total (14)C, but increased levels in urine. In all cases, however, the ratio of the two amines to total (14)C was not significantly different from controls.6. From the foregoing experiments it was concluded that the results in (2) could be largely attributed to entry into urine of (14)C-histamine and total (14)C, thus reducing the availability of these substances in blood for extraction by tissues. In stomach, the cortisol-induced increase in histamine formation may involve some process other than increased histidine decarboxylase activity.7. The activation of histidine decarboxylase in liver and lung of intact mice by Freund's adjuvant, or by endotoxin, was reduced by corticoid treatment.8. In a single short experiment on the effect of cortisol on histamine formation in adrenalectomized rats, results from stomach, lung and heart, the only tissues assayed, were similar to those from the mouse experiment.

Adrenalectomy↗

Techniques for measring histamine formation in mice.

1. Formation of (14)C-histamine from (14)C-L-histidine was studied in mice using various inhibitors of histamine catabolism; these included aminoguanidine, pargyline and methylhistamine, inhibitors of diamine oxidase, monoamine oxidase, and the histamine-methylating enzyme, respectively.2. Four general approaches were used: inhibiting diamine oxidase and the histamine-methylating enzyme and measuring (14)C-histamine in tissues or urine, or inhibiting diamine oxidase and monoamine oxidase and measuring (14)C-methylhistamine in tissues or urine. In some tests mice with normal concentrations of histidine decarboxylase were used; in others the enzyme was activated by pretreating mice with Freund's adjuvant.3. Methylhistamine pretreatment increased (14)C-histamine in several tissues of mice but aminoguanidine had no significant effect; it was concluded that endogenously formed histamine is inactivated almost entirely by methylation.4. There was no evidence of parallelism between the ability of tissues to form histamine and to inactivate endogenous histamine.5. Effects of Freund's adjuvant on tissue concentrations of (14)C-histamine were tested in mice with or without inhibitors of histamine catabolism. Results were essentially parallel in both cases but higher in the former.6. The method of choice is measurement of (14)C-histamine in tissues of mice given aminoguanidine and methylhistamine, followed by (14)C-L-histidine.7. Other approaches listed above may be useful but require improvement, for example, a more specific assay for (14)C-methylhistamine and a stronger, longer-lasting inhibitor of histamine-methylation.

Amine Oxidase (Copper-Containing)↗

Further studies on histamine catabolism in vivo.

1. Histamine catabolism in vivo was studied in mice and rats; tissues from animals killed 2.5 min after intravenous injection of (14)C-histamine were assayed for (14)C-histamine and total (14)C. Aminoguanidine, a diamine oxidase inhibitor, and methylhistamine, an inhibitor of the histamine methylating enzyme, were used to evaluate the roles of these enzymes in individual tissues.2. Mouse liver and lung appeared to catabolize exogenous histamine rapidly and completely by methylation. In vivo histamine methylating activity was also found in mouse muscle, heart, kidney and lymph node, but not in stomach or intestine.3. In rats (14)C-histamine was inactivated more slowly than in mice. Catabolism was most rapid in intestine where both diamine oxidase and methylating activities were found. Liver had only diamine oxidase activity. Heart showed no catabolism but had extraordinary ability to extract (14)C-histamine from blood.4. The in vivo evaluation of histamine methylation by individual mouse and rat tissues agrees closely with in vitro findings by another laboratory.5. Aminoguanidine reduced uptake of blood (14)C-histamine by some tissues presumably by occupying sites where histamine is normally bound.6. The marked differences between tissues of mice and rats in destroying (14)C-histamine support earlier evidence that there is no apparent relationship between histamine catabolism and function.7. Urine from mice with both major catabolic pathways blocked showed evidence of an abnormal excretory product of (14)C-histamine. Paper chromatograms of urine of male and female mice showed no evidence of a sex difference in catabolism of injected (14)C-histamine.8. A procedure which may permit evaluating contributions of individual tissues to histamine formation in vivo is presented.9. Pretreatment of mice with antihistamines, or with a histamine analogue, betahistine, did not significantly affect the rate of in vivo(14)C-histamine inactivation.

Amine Oxidase (Copper-Containing)↗

In vivo studies on histamine catabolism and its inhibition.

1. Histamine catabolism in vivo was studied in mice subjected to various forms of pretreatment; tissues from mice killed 2.5 min after intravenous injection of (14)C-histamine were assayed for (14)C-histamine, (14)C-methylhistamine and total (14)C.2. Pretreatment of mice with aminoguanidine, an inhibitor of diamine oxidase, strongly increased levels of (14)C-histamine in intestine; pretreatment with aminoguanidine plus a monoamine oxidase inhibitor strongly increased levels of (14)C-methylhistamine in liver. Effects in other tissues are reported and discussed.3. Pretreatment of mice with non-isotopic methylhistamine increased levels of (14)C-histamine in liver. Methylhistamine is the first known inhibitor of histamine-methylation in vivo.4. Pretreatment of mice with inhibitors of protein synthesis, drugs which reduce the basal activity of histidine decarboxylase and which block its activation, failed to affect histamine catabolism.5. Pretreatment of mice with endotoxin or with Freund's adjuvant, irritants known to cause activation of histidine decarboxylase, failed to affect histamine catabolism.6. There was no evidence of parallelism between the histamine-destroying enzymes and the histamine-forming enzyme, histidine decarboxylase, either in distribution or ability to undergo changes in activity. No support was obtained for the view that histamine-catabolizing enzymes play a role in the local control of responses to newly formed histamine.

Amine Oxidase (Copper-Containing)↗

Enhancement of inflammation and histamine formation by actinomycin D.

1. An inflammation model developed in other laboratories was used in this study. Mice given endotoxin intranasally developed lung inflammation which progresses in intensity for several days. Lung weight is a satisfactory measure of inflammation.2. In lungs of mice treated intranasally with endotoxin, histidine decarboxylase was activated within 6 hr, before lung weight had increased substantially. Enzyme activity was near maximal at 24 hr but had dropped by 48 hr, at which time inflammation was increasing. The data are consistent with an early role for histamine in mediating inflammation, but not with an essential role in the later stages.3. When actinomycin D, an inhibitor of RNA synthesis, was mixed with endotoxin solution and given to mice intranasally, both lung inflammation and histidine decarboxylase activation were markedly enhanced at 24 and 48 hr, relative to effects produced by endotoxin alone.4. Evidence is presented that intranasal instillation of endotoxin into mice increases histamine formation in lung in vivo.5. We previously found protein synthesis inhibitors, the only drugs shown capable of blocking histidine decarboxylase activation, to be powerful anti-inflammatory agents. Now we have found that actinomycin D, the only drug shown capable of enhancing histidine decarboxylase activation, to be strongly pro-inflammatory. These observations support a causative role for histamine in slowly-developing inflammation, and also provide a rigorous test for the participation of other mediator candidates.

Animals↗

Further studies on the histidine-histamine relationship in vivo: effects of endotoxin and of histidine decarboxylase inhibitors.

1. Mice were injected with ((14)C)-L-histidine, killed at various intervals, and tissues assayed for ((14)C)-histamine. In some cases free ((14)C)-L-histidine and total ((14)C) were also determined.2. Removal of stomach, the most active histamine-forming tissue, failed to reduce the ((14)C)-histamine content of any tested tissue; ((14)C)-histamine concentrations in lung and muscle of gastrectomized mice were higher than in shamoperated controls.3. In mice pretreated with endotoxin and subsequently injected with ((14)C)-L-histidine, the ((14)C)-histamine content of liver, lung and muscle was markedly higher than in controls. The increased concentrations of ((14)C)-histamine in endotoxin-pretreated mice seemed to reflect a greater rate of formation; they could be attributed neither to changes in tissue concentration of ((14)C)-L-histidine, to increased uptake from other tissues, nor to impaired ability to inactivate histamine.4. Results of studies on in vivo effectiveness of several histidine decarboxylase inhibitors are reported.5. The following conclusions are supported by the evidence presented: (a) in stressed mice, those tissues which show activation of histidine decarboxylase also show increased ability to form histamine in vivo; (b) tissue histamine is largely formed locally; (c) histidine decarboxylase inhibitors are highly effective in blocking histamine formation in mast cells and in stomach, but do not normally reach the locus of an inducible form of histidine decarboxylase; (d) the inducible form of histidine decarboxylase in liver may be located in phagocytic microvascular endothelial cells; (e) in conditions favouring near-maximal activation of histidine decarboxylase, the histamine-methylating enzyme of liver and diamine oxidase of intestine showed no inducible characteristics; (f) blood histamine concentrations do not accurately reflect changes in tissue histamine formation.

Animals↗

Influence of chronic lithium administration on binding to benzodiazepine- and histamine H1-receptors in rat brain.

In rat, chronic lithium treatment lowered the Kd of [3H]-mepyramine in midbrain, and reduced the Bmax in midbrain and pons-medulla. Binding of [3H]flunitrazepam in cerebellum and midbrain was not altered. The suggestion that some actions of lithium may occur by way of central nervous system receptors is further supported by these observations that lithium's effects on neurotransmitter systems are regional and specific.

Animals↗